BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21153681)

  • 21. Intracarotid tumor necrosis factor-alpha administration increases the blood-brain barrier permeability in cerebral cortex of the newborn pig: quantitative aspects of double-labelling studies and confocal laser scanning analysis.
    Abraham CS; Deli MA; Joo F; Megyeri P; Torpier G
    Neurosci Lett; 1996 Apr; 208(2):85-8. PubMed ID: 8859896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noninvasive in vivo optical assessment of blood brain barrier permeability and brain tissue drug deposition in rabbits.
    Ergin A; Wang M; Zhang J; Bigio I; Joshi S
    J Biomed Opt; 2012 May; 17(5):057008. PubMed ID: 22612147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracarotid administration of short-chain alkylglycerols for increased delivery of methotrexate to the rat brain.
    Erdlenbruch B; Schinkhof C; Kugler W; Heinemann DE; Herms J; Eibl H; Lakomek M
    Br J Pharmacol; 2003 Jun; 139(4):685-94. PubMed ID: 12812991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans.
    Siegal T; Rubinstein R; Bokstein F; Schwartz A; Lossos A; Shalom E; Chisin R; Gomori JM
    J Neurosurg; 2000 Apr; 92(4):599-605. PubMed ID: 10761648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study with positron emission tomography of the osmotic opening of the dog blood-brain barrier for quinidine and morphine.
    Agon P; Kaufman JM; Goethals P; Van Haver D; Bogaert MG
    J Pharm Pharmacol; 1988 Aug; 40(8):539-43. PubMed ID: 2907006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intragastric accumulation of Evan's blue as a method for assessing aspirin-induced acute gastric mucosal injury in humans.
    Woods KL; Smith JL; Graham DY
    Dig Dis Sci; 1988 Jul; 33(7):769-73. PubMed ID: 3259918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyamines mediate the reversible opening of the blood-brain barrier by the intracarotid infusion of hyperosmolal mannitol.
    Koenig H; Goldstone AD; Lu CY
    Brain Res; 1989 Mar; 483(1):110-6. PubMed ID: 2495841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opening of the blood-brain barrier by intravenous contrast media in euvolemic and dehydrated rabbits.
    Hayakawa K; Morris TM; Katzberg RW
    Acta Radiol; 1989; 30(4):439-44. PubMed ID: 2505832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electroencephalographic consequences of sodium dehydrocholate-induced blood-brain barrier disruption: Part 1. Acute and chronic effects of intracarotid sodium dehydrocholate.
    Zappulla RA; Spigelman MK; Omsberg E; Rosen JJ; Malis LI; Holland JF
    Neurosurgery; 1985 May; 16(5):630-8. PubMed ID: 4000434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood-brain barrier disruption using mannitol: time course and electron microscopy studies.
    Cosolo WC; Martinello P; Louis WJ; Christophidis N
    Am J Physiol; 1989 Feb; 256(2 Pt 2):R443-7. PubMed ID: 2492773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered blood-brain barrier permeability and its effect on the distribution of Evans blue and sodium fluorescein in the rat brain applied by intracarotid injection.
    Kozler P; Pokorný J
    Physiol Res; 2003; 52(5):607-14. PubMed ID: 14535837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inability of dimethyl sulfoxide and 5-fluorouracil to open the blood-brain barrier.
    Neuwelt EA; Barnett P; Barranger J; McCormick C; Pagel M; Frenkel E
    Neurosurgery; 1983 Jan; 12(1):29-34. PubMed ID: 6219298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracarotid infusions of protamine sulfate disrupt the blood-brain barrier of rabbits.
    Strausbaugh LJ
    Brain Res; 1987 Apr; 409(2):221-6. PubMed ID: 3580873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
    Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood brain barrier breakdown was found in non-infarcted area after 2-h MCAO.
    Wang X; Liu Y; Sun Y; Liu W; Jin X
    J Neurol Sci; 2016 Apr; 363():63-8. PubMed ID: 27000223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rat model of blood-brain barrier disruption to allow targeted neurovascular therapeutics.
    Martin JA; Maris AS; Ehtesham M; Singer RJ
    J Vis Exp; 2012 Nov; (69):e50019. PubMed ID: 23222697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of the blood-brain barrier permeability following intracarotid infusion of vinorelbine.
    Mouchard-Delmas C; Gourdier B; Vistelle R; Wiczewski M
    Anticancer Res; 1995; 15(6B):2593-6. PubMed ID: 8669830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood-brain barrier disruption in immature Fischer 344 rats.
    Bullard DE; Bigner DD
    J Neurosurg; 1984 Apr; 60(4):743-50. PubMed ID: 6423781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of osmotic blood-brain barrier disruption on gentamicin penetration into the cerebrospinal fluid and brains of normal rabbits.
    Strausbaugh LJ; Brinker GS
    Antimicrob Agents Chemother; 1983 Aug; 24(2):147-50. PubMed ID: 6416158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiological and electrophysiological consequences of etoposide-induced blood-brain barrier disruption.
    Hollis PH; Zappulla RA; Spigelman MK; Feuer EJ; Johnson J; Holland JF; Malis LI
    Neurosurgery; 1986 May; 18(5):581-6. PubMed ID: 3714006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.